![](/images/graphics-bg.png)
Chinese Herbal Formula Xuefu Zhuyu for Stable Angina (CheruSA): Study Protocol for a Multicenter Randomized Controlled Trial
المؤلفون المشاركون
Zhang, Ni
Wen, Zehuai
Liao, Shaojun
Zhou, Li
Zhang, Zhe
Jiang, Junwen
Du, Yi
Wang, Yang
Li, Geng
المصدر
Evidence-Based Complementary and Alternative Medicine
العدد
المجلد 2020، العدد 2020 (31 ديسمبر/كانون الأول 2020)، ص ص. 1-10، 10ص.
الناشر
Hindawi Publishing Corporation
تاريخ النشر
2020-08-31
دولة النشر
مصر
عدد الصفحات
10
التخصصات الرئيسية
الملخص EN
Introduction.
Stable angina (SA) in coronary heart disease is a common ischemic heart disease endangering the patient’s quality of life and longevity.
Clinical trials have demonstrated that the Chinese herbal formula Xuefu Zhuyu (XFZY) has benefits for SA patients.
However, there remains a lack of high-quality evidence to support clinical decision-making.
Therefore, we designed a randomized controlled trial (RCT) to evaluate the efficacy and safety of XFZY for SA.
Methods and Analysis.
This multicenter, double-blinded RCT will be conducted in China.
152 eligible participants will be randomly assigned to either an XFZY group or a control group at a 1 : 1 ratio.
Participants in the XFZY group will receive XFZY plus routine care, while those in the control group will receive placebo plus routine care.
The study period is 26 weeks, including a 2-week run-in period, a 12-week treatment period, and a 12-week follow-up.
The primary outcome is the change in visual analogue scale score for angina pain intensity from baseline to 12 weeks.
The secondary outcomes are the angina attack frequency and duration, the nitroglycerin dosage consumed, the Canadian Cardiovascular Society grading of effort angina, the Seattle Angina Questionnaire, the EuroQol-5-Dimensions-5-Level, the incidence of major adverse cardiac events, health cost evaluation, and overall assessment for study drugs.
Ethics and Dissemination.
The study has been approved by the ethics committee of Guangdong Provincial Hospital of Chinese Medicine (approval no.
BF2019-175-01).
Results will be submitted for publication in peer-reviewed journals and disseminated at scientific conferences.
This trial is registered with ChiCTR1900026899, registered on 26 October 2019.
نمط استشهاد جمعية علماء النفس الأمريكية (APA)
Liao, Shaojun& Zhang, Zhe& Li, Geng& Zhou, Li& Jiang, Junwen& Zhang, Ni…[et al.]. 2020. Chinese Herbal Formula Xuefu Zhuyu for Stable Angina (CheruSA): Study Protocol for a Multicenter Randomized Controlled Trial. Evidence-Based Complementary and Alternative Medicine،Vol. 2020, no. 2020, pp.1-10.
https://search.emarefa.net/detail/BIM-1157308
نمط استشهاد الجمعية الأمريكية للغات الحديثة (MLA)
Liao, Shaojun…[et al.]. Chinese Herbal Formula Xuefu Zhuyu for Stable Angina (CheruSA): Study Protocol for a Multicenter Randomized Controlled Trial. Evidence-Based Complementary and Alternative Medicine No. 2020 (2020), pp.1-10.
https://search.emarefa.net/detail/BIM-1157308
نمط استشهاد الجمعية الطبية الأمريكية (AMA)
Liao, Shaojun& Zhang, Zhe& Li, Geng& Zhou, Li& Jiang, Junwen& Zhang, Ni…[et al.]. Chinese Herbal Formula Xuefu Zhuyu for Stable Angina (CheruSA): Study Protocol for a Multicenter Randomized Controlled Trial. Evidence-Based Complementary and Alternative Medicine. 2020. Vol. 2020, no. 2020, pp.1-10.
https://search.emarefa.net/detail/BIM-1157308
نوع البيانات
مقالات
لغة النص
الإنجليزية
الملاحظات
Includes bibliographical references
رقم السجل
BIM-1157308
قاعدة معامل التأثير والاستشهادات المرجعية العربي "ارسيف Arcif"
أضخم قاعدة بيانات عربية للاستشهادات المرجعية للمجلات العلمية المحكمة الصادرة في العالم العربي
![](/images/ebook-kashef.png)
تقوم هذه الخدمة بالتحقق من التشابه أو الانتحال في الأبحاث والمقالات العلمية والأطروحات الجامعية والكتب والأبحاث باللغة العربية، وتحديد درجة التشابه أو أصالة الأعمال البحثية وحماية ملكيتها الفكرية. تعرف اكثر
![](/images/kashef-image.png)